Found 135 matching trials
Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma PHASE2 The use of R-CHOP, given every two weeks, will be associated with improveme...
Show More Location
USC Norris Comprehensive Cancer Center
Learn More & Join Trial
Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma PHASE2 This phase II trial is studying how well giving combination chemotherapy to...
Show More Learn More & Join Trial
Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma PHASE3 Primary objective of the study is to compare the efficacy of romidepsin whe...
Show More Learn More & Join Trial
Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma PHASE3 The goal of this clinical trial is to study the addition of Acalabrutinib t...
Show More Location
Saarland University Medical Center
Learn More & Join Trial
Addressing Traumatic Stress Symptoms in Children NA The objective of this study is to evaluate the effectiveness of the Child a...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma PHASE1 This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Learn More & Join Trial
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Bendamustine Plus Rituximab Versus CHOP Plus Rituximab PHASE3 The study addresses the question if the first line therapy of low malignant...
Show More Location
StiL Head Office; Justus-Liebig-University
Learn More & Join Trial
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma PHASE2 About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Show More Location
Memorial Sloan Kettering Cancer Center
Treatments Being Tested
Etoposide, carboplatin, ifosfamide Rituximab, Ifosfamide, Etoposide, Carboplatin Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustine Learn More & Join Trial
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients PHASE2 This is a prospective, single-arm, multi-center, phase II clinical study to...
Show More Location
Department of Medical Oncology, Sun Yat-Sen University Cancer Center
Learn More & Join Trial